Data / Form D filings / Valeo Pharma Inc.
Valeo Pharma Inc.: Form D filing
Valeo Pharma Inc., a pharmaceuticals company in Kirkland, Quebec, Canada, filed a Form D with the SEC in 2022. The latest, on January 13, 2022, reports $787,400 sold of a $787,400 offering to 1 investor.
Find out what Valeo Pharma Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 16667, HYMUS BLVD., Kirkland, Quebec, Canada, H9H 4
- Phone
- (514) 693-8832
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1904395
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 13, 2022 | New notice | $787,400 | $787,400 | $0 | 1 | Dec 9, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeff P. Skinner | Executive Officer | |
| Vincent P. Hogue | Director | |
| Frederic J. Fasano | Executive Officer, Director | |
| Michel P. Trudeau | Director | |
| Steve J. Saviuk | Executive Officer, Director | |
| Michael G. Wells | Director | |
| Richard J. Mackay | Executive Officer, Director | |
| Guy-Paul Allard | Executive Officer | |
| Luc P. Mainville | Executive Officer | |
| Helen P. Saviuk | Executive Officer | |
| Michelle P. Brien | Executive Officer | |
| Nathalie P. Therrien | Executive Officer | |
| Nelly P. Komari | Executive Officer | |
| Maureen C. Breenan | Director |
Every Form D from the week of Jan 10, 2022 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Valeo Pharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.